InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
1.620
-0.050 (-2.99%)
At close: Jul 8, 2026, 4:00 PM EDT
1.660
+0.040 (2.47%)
After-hours: Jul 8, 2026, 4:10 PM EDT
InMed Pharmaceuticals Market Cap
InMed Pharmaceuticals has a market cap or net worth of $7.23 million as of July 8, 2026. Its market cap has increased by 144.53% in one year.
Market Cap
7.23M
Enterprise Value
2.41M
1-Year Change
144.53%
Ranking
Category
Stock Price
$1.62
Market Cap Chart
Since May 6, 2014, InMed Pharmaceuticals's market cap has decreased from $9.40M to $7.23M, a decrease of -23.06%. That is a compound annual growth rate of -2.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 8, 2026 | 7.23M | 72.54% |
| Dec 31, 2025 | 4.19M | 22.12% |
| Dec 31, 2024 | 3.43M | 57.02% |
| Dec 29, 2023 | 2.19M | -31.94% |
| Dec 30, 2022 | 3.21M | -82.66% |
| Dec 31, 2021 | 18.52M | -19.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biofrontera | 14.85M |
| Caring Brands | 12.55M |
| Apimeds Pharmaceuticals US | 11.21M |
| Akanda | 8.97M |
| cbdMD | 7.75M |
| Gelteq | 6.50M |
| Sonoma Pharmaceuticals | 5.89M |
| RedHill Biopharma | 4.47M |